Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine?
Scagliotti
Giorgio V
GV
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. giorgio.scagliotti@unito.it
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics; D002945:Cisplatin / Q000008:administration & dosage; D003362:Cost-Benefit Analysis; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics; D014747:Vinblastine / Q000008:administration & dosage; D000093542:Gemcitabine
D003841:Deoxycytidine; D014747:Vinblastine; D002945:Cisplatin; D000093542:Gemcitabine